Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers To investigate the steady-state pharmacokinetics of once-daily and twice-daily regimens of BIA 2-093 and twice-daily regimen of Oxcarbazepine (Trileptal®) in healthy subjects and to assess...

• Country None
• organs None
• Specialty None

Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers To investigate the pharmacokinetics of a single 900 mg oral dose of BIA 2-093 and a single 900 mg oral dose of Oxcarbazepine in healthy volunteers and to assess the tolerability of a singl...

• Country None
• organs None
• Specialty None

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic To investigate the effect of repeated dosing of BIA 9-1067 on the levodopa pharmacokinetics, in comparison to placebo and entacapone.

• Country Portugal
• organs None
• Specialty None

Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers The primary objective was to investigate whether multiple-dose administration of eslicarbazepine acetate affects the pharmacokinetics of metformin.

• Country Portugal
• organs None
• Specialty None

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide The purpose of this study is to investigate the CYP2C8 inhibition by BIA 9-1067.

• Country Portugal
• organs None
• Specialty None